Submitted by Bloodworks Northwest
With new COVID-19 cases in the Northwest projected to decline in the weeks ahead, Washington and Oregon hospitals are preparing to re-start surgeries, organ transplants and cancer treatments that were suspended in March after the magnitude of the pandemic threat became apparent. Patient needs and requests for blood from Bloodworks healthcare partners are rising quickly and could reach pre-COVID levels as early as next week before the blood supply is ready.
Whenthe coronavirus hit, donors in the community stepped up immediately, said CurtBailey, President and CEO of Bloodworks Northwest. As we start the challengingroad to recovery, patients need them even more.
Hospitals and healthcare providers in the region are preparing to tackle a significant backlog of surgeries, medical treatments and procedures that require transfusions. Mounting requests from hospitals are outpacing current collection levels. We cannot afford to re-start these and other treatments without being utterly certain the blood will be there and steadily available over the coming days and months, and only the community can close the gap, Bailey said.
Essential measures to contain the coronavirus stay-at-home orders, online learning at colleges and schools, workplace and business closures, social distancing to discourage public and faith-based gatherings also took away usual settings for mobile blood drives that account for up to 60% of collections (the equivalent of 34,000 units since March 1). The sacrifices necessary for a safe and healthy community have been felt and shared by everyone, Bailey noted. After conserving the blood supply in recent weeks, we must rebuild inventory to a higher, resilient level that will propel the community toward a safe, sustainable recovery.
Bloodworks has implemented some creative new approaches to blood collection, said Vicki Finson, Executive Vice President of Blood Services. With donor support, we can make the most of them to restore the blood supply for people whove been patiently awaiting their turn. Were determined to be ready for patients and to support our healthcare partners, however, right now the need is outpacing the supply. Only by boosting current collections and calling on donors to book appointments can we meet the critical need hospitals have identified for the weeks ahead.
Inextraordinary times like these (and in normal times, too) the community bloodsupply supports patients receiving trauma care, undergoing surgeries, cancertreatment, organ transplants, plus new moms and neonatal care.
Bloodworks is urging all donors to step up for community recovery.Please pre-book your next severaldonations now to make sure patients get the fighting chance andlifesaving blood they deserve. All types are urgently needed, but Type O isespecially in demand.
Theblood components in greatest demand are perishable, just like milk. Plateletshave a shelf-life of only 5 days; red cells can be stored for up to 42 days.Thats why donors are needed every day. The community will have a safe andreliable blood supply when donating blood becomes a kindhearted habitwhendonors commit to donating two or three times per year or more.
Wewelcome regular and new donors as humble heroes to save lives and to help inCOVID recovery.
Now more than ever the act of donating blood is a way for peopleto look after their families,friends, coworkers and neighbors, Bailey said. Whenit comes to a safe and resilient blood supply, lets be the community thatleads the nation.
Before COVID-19,about 60% of the blood supply was collected through mobile drives hosted bydrive sponsors who organized drives at schools, workplaces, offices, factories,communityspaces and places of worship. Due to social distancing, Bloodworks is no longerdoing one-time only mobile drives. Instead, pop-up donor centers aremulti-week drives in spacious, temporary venues like T-Mobile Park, Cheney Stadium, Angel of the Winds Arena along with manyother area businesses and churches which are providing the opportunity forhundreds of donor appointments per day. Extended hours at donor centersalso play a key role.
Whole blood donors can giveblood once every 56 days, up to 6 times a year. Those aged 16 & 17 who meetdonation weight and eligibility requirements may donate with a signed Bloodworkspermission form.
Appointments arerequired to donate blood, and no guests or people under the age of 16 arepermitted onsite to support safe social distancing, minimize wait time, andensure the best donation experience possible. Same day appointments are oftenavailable by calling ahead to 800-398-7888. Special appointments have beenreserved for donors who are blood type O negative in this crucial time, soplease contact us at 800-398-7888 or email schedule@bloodworksnw.org if this is your blood type.
Donating blood is safe, and there is no risk of contracting coronavirus from the donation process. (Source: AABB) Bloodworks policies comply with FDA, CDC, local health departments and other recommendations related to COVID-19. Bloodworks follows CDC guidance on wearing masks by wearing cloth face masks donated by volunteers or a face shield. We encourage donors to wear masks to their donation appointments and whenever they are in public. Bloodworks routinely sanitizes donation areas, chairs, surfaces and common objects such as doorknobs and light switches, and use hand sanitizer. Staff, donors, and volunteers are advised to stay home if they feel unwell. Bloodworks has posted information addressing questions and concerns for blood donors at bloodworksnw.org/coronavirus.
Blood donation takes about an hour from registration to post-donation refreshment. Information about who can donate and where is available at http://www.bloodworksnw.org.
For the latest information on COVID-19 please visit theCDC website and Washington State Department of Health COVID-19 main page.
Appointments and information at BloodworksNW.org or800-398-7888..
Bloodworks Northwest is backed by 75 years of Northwest history and 250,000 donors. It is local, nonprofit, independent, volunteer-supported and community-based. A recognized leader in transfusion medicine, Bloodworks serves patients at hospitals in Washington, Oregon and Alaska partnering closely with local hospitals to deliver the highest level of patient care. Comprehensive services include blood components, complex cross-matching, specialized lab services for organ transplants, care for patients with blood disorders, and collection of cord blood stem cells for cancer treatment. Bloodworks Research Institute performs leading-edge research in blood biology, transfusion medicine, blood storage and treatment of blood disorders. Patients with traumatic injuries, undergoing surgeries or organ transplantation or receiving treatment for cancer and blood disorders all depend on our services, expertise, laboratories and research. Blood donation appointments can be scheduled at bloodworksnw.org.
See the article here:
Hospitals to Resume Elective Surgeries, Triggering a Surge in Blood Needs - southsoundtalk.com
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
- Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire - January 16th, 2024
- Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering - January 11th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 4th, 2024
- askST: Can cord blood units be transferred from one bank to another? - The Straits Times - December 27th, 2023
- Timeline: Cordlife's mishandling of cord blood units in Singapore - CNA - December 15th, 2023
- Next-Level Evolution: Enhancing the Human Body With Anthrobots ... - Securities.io - December 5th, 2023
- Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ... - Fred Hutchinson Cancer Center - December 5th, 2023
- Enhancing the immunosuppressive properties of human umbilical ... - Phys.org - December 1st, 2023
- Global Status and Trends for Thromboangiitis Obliterans | JPR - Dove Medical Press - December 1st, 2023
- Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis - University of Colorado Anschutz Medical Campus - December 1st, 2023
- Global Medical Specialty Bag Market is Expected to Reach US$ 9.4 Billion by 2034, Rising at a Steady 4.7% CAGR | Future Market Insights, Inc. - Yahoo... - November 29th, 2023
- Repeated concussions can alter heart activity and impact the heart ... - Philippine Canadian Inquirer - November 29th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - PharmiWeb.com - November 27th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - Marketscreener.com - November 25th, 2023
- FY 2021 VA-Funded Projects - VA's Office of Research and Development - November 25th, 2023
- New study aims to expand access to stem cell transplant using ... - Healio - November 23rd, 2023
- Impact of GVHD Prophylaxis on CMV Reactivation and Disease ... - Cancer Network - November 23rd, 2023
- The Top 25 Women Leaders in Biotechnology of 2023 - The Healthcare Technology Report. - November 21st, 2023
- First Edition: November 20, 2023 - KFF Health News - November 21st, 2023
- An essential guide to the building blocks of life - Gates Notes - November 21st, 2023
- A Simple Way to Save Premature Babies - The New York Times - November 19th, 2023
- Perspectives of current understanding and therapeutics of Diamond ... - Nature.com - November 17th, 2023
- Brain Organoids: Should They Be Considered People? - BBVA OpenMind - November 17th, 2023
- Understanding the cause of childhood Alzheimer's - ASBMB Today - November 17th, 2023
- Peripheral nerve regeneration through nanofiber scaffolds | IJN - Dove Medical Press - November 15th, 2023
- Are STEM CELL EXOSOMES the secret to a 'snatched' jawline? Discover the products that influencers are claiming - Daily Mail - November 13th, 2023
- CAR-NK: The next generation in hematological malignancy treatment - News-Medical.Net - November 13th, 2023
- Regenerative Medicine | Top Regenerative Medicine Solution ... - Healthcare Tech Outlook - November 13th, 2023
- Stem cell therapy, emerging solution to slow down ageing - Punch Newspapers - November 13th, 2023
- Improving Cord Blood Transplantation Outcomes for Adults With ... - On Cancer - Memorial Sloan Kettering - November 11th, 2023
- 8 Ways To Save Lives With Canadian Blood Services & You Can ... - Narcity Canada - November 11th, 2023
- Internal investigation by Vita 34 AG reveals irregularities related to a ... - Marketscreener.com - November 11th, 2023
- 'We worried the worst would happen' - Yorkshire Children's Trust ... - The Yorkshire Post - November 11th, 2023
- Minor GPI(-) granulocyte populations in aplastic anemia and healthy ... - Nature.com - November 9th, 2023
- Repeated treatment with ProTrans is immunologically safe ... - Marketscreener.com - November 7th, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells - Benzinga - November 7th, 2023
- Health Canada issues warning on cord blood stored in Edmonton - CBC News - November 3rd, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting - Yahoo... - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance ... - InvestorsObserver - November 3rd, 2023
- Go with the flow and achieve hearing restoration - Drug Discovery News - November 3rd, 2023
- Cell Therapy Market to Witness Exponential Growth by 2031 ... - Argyle Report - November 1st, 2023
- Cross-talk between Myeloid and B Cells Shapes the Distinct ... - Cancer Discovery - November 1st, 2023
- Comparison of effects of HucMSCs, exosomes, and conditioned ... - Nature.com - October 28th, 2023
- The structural and functional complexity of the integrative ... - Science - October 28th, 2023
- Global Primary Cells Market to Witness Growth at 11.41% CAGR to ... - GlobeNewswire - October 26th, 2023
- Hma-Qubec celebrates 25 years of giving life in anniversary ad - - The Message - October 26th, 2023
- Improvement of thermal-stability of chondroitinase ABCI immobilized ... - Nature.com - October 26th, 2023
- Sydney Couple Overcomes Sperm Antibody Issue to Welcome Baby - OPP.Today - October 24th, 2023
- New Research Reveals Surprising Issue with Sperm and Fertility - CityLife - October 24th, 2023
- Biobanking Market to Observe Prominent CAGR of 6.10% by 2029 ... - PharmiWeb.com - October 21st, 2023
- TV shows like BBC's Call The Midwife and C4's One Born Every Minute 'are inaccurately depicting childbirth' an - Daily Mail - October 19th, 2023
- Advances in medical and technological research and SCI - Clyde & Co - October 18th, 2023
- Prognostic Value of Hematogones in Patients With Hematopoietic ... - Cureus - October 18th, 2023
- Stem-Cell Therapy: Filling Gaps in Oro-Maxillofacial Region - Cureus - October 18th, 2023
- The neonatal southern white rhinoceros ovary contains oogonia in ... - Nature.com - October 18th, 2023
- OMG: Sperm injury led to rare baby struggle - news.com.au - October 18th, 2023
- Experts Explain how MS Impacts the Eyes and Eye Health - Health Central - October 18th, 2023
- Newly identified stem cells can lure breast cancer to the spine - Science News Magazine - October 15th, 2023
- Cases of HIV cure | aidsmap - aidsmap - October 15th, 2023
- HokUS-10 scoring system predicts the treatment outcome for ... - Nature.com - October 13th, 2023
Recent Comments